Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Group 1 - The article discusses the author's long-standing interest in Ironwood Pharmaceuticals, particularly in relation to its potential in the biotech sector [1] - The author emphasizes the focus on innovative companies that are developing breakthrough therapies and pharmaceuticals, indicating a strategic investment approach [1] - The article highlights the features of the author's investment group, Compounding Healthcare, which includes model healthcare portfolios and a weekly newsletter [1] Group 2 - The author has disclosed a beneficial long position in ABBV shares, indicating a personal investment interest [2] - The article clarifies that the opinions expressed are solely those of the author and not influenced by any business relationships with mentioned companies [2] - It is noted that past performance does not guarantee future results, emphasizing the speculative nature of investments [3]